UROGENITAL CANCER
Clinical trials for UROGENITAL CANCER explained in plain language.
Never miss a new study
Get alerted when new UROGENITAL CANCER trials appear
Sign up with your email to follow new studies for UROGENITAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test powerful new drug duo to rally immune system against spreading cancers
Disease control Recruiting nowThis early-stage study is testing the safety of a new two-drug immunotherapy combination, with or without a precise form of radiation, for adults with advanced urinary tract cancers that have spread. The goal is to see if these treatments can work together to help the body's own …
Matched conditions: UROGENITAL CANCER
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Immune-Boosting drug trial aims to make cancer surgery more effective
Disease control Recruiting nowThis study is testing whether a drug called atezolizumab can shrink tumors in patients with bladder or upper urinary tract cancer before they have surgery to remove them. The drug works by helping the patient's own immune system recognize and attack the cancer cells. About 58 pat…
Matched conditions: UROGENITAL CANCER
Phase: PHASE2 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Landmark study hunts clues in rare urinary cancers
Knowledge-focused Recruiting nowThis study aims to understand the course of rare cancers in the urinary system (like bladder, kidney, and prostate cancers) by tracking patients over time. Researchers will collect medical information, blood, urine, and sometimes tumor samples from about 1,100 adults with these c…
Matched conditions: UROGENITAL CANCER
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC